v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows used in operating activities:    
Net loss $ (15,804,655) $ (8,962,472)
Stock based compensation 1,147,236 1,258,890
Amortization of intangibles 100,000 100,000
Realized and unrealized gain and accrued interest on investments (215,855) (251,590)
Changes in assets and liabilities:    
Increase (decrease) in accounts payable and accrued expenses 1,325,128 275,955
Decrease in prepaid expenses and other assets (92,848) (278,092)
Net cash used in operating activities (13,540,994) (7,857,309)
Cash flows provided by investing activities:    
Purchase of investments (12,264,069) (17,254,282)
Proceeds from redemption of investments 7,986,294 15,366,000
Net cash used by investing activities (4,277,775) (1,888,282)
Cash flows (used in) provided by financing activities:    
Payment of amounts due to officers (600,000) (600,000)
Proceeds from sale of equity securities, net 18,614,135 11,567,736
Net cash provided by financing activities 18,014,135 10,967,736
Effect of foreign exchange rate on changes on cash (613)  
Net change in cash and cash equivalents: 194,753 1,222,145
Cash and cash equivalents - beginning of year 3,623,343 2,401,198
Cash and cash equivalents - end of year 3,818,096 3,623,343
Supplemental information - Non cash items:    
Offering expenses associated with warrant modification   1,725,148
Accrued offering expenses included in additional paid in capital $ 40,870 $ 323,497